Perspective: Hepatocyte-Directed Base Editing as Novel Treatment for Human Dyslipidemia-Current Status and Remaining

Menno Hoekstra1,2, Miranda Van Eck1,2,3, Theo J C Van Berkel1

  • 1Division of BioTherapeutics (M.H., M.V.E., T.J.C.V.B.), Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.